AbCellera and Lilly broadens antibody discovery partnership

AbCellera and Lilly Expand Collaboration to Develop Antibody ...

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) announced today that it has expanded its existing collaboration with ...

AbCellera Biologics has broadened its partnership with Eli Lilly to discover therapeutic antibodies for various diseases.

AbCellera and Lilly broadens antibody discovery partnership

In March 2024, AbCellera signed a partnership deal with Biogen for the discovery of therapeutic antibodies for neurological ailments. The ...

AbCellera and Lilly Expand Collaboration to Develop Antibody ...

AbCellera (Nasdaq: ABCL) announced today that it has expanded its existing collaboration with Eli Lilly and Company (Lilly) to discover therapeutic antibodies.

AbCellera and Lilly Expand Collaboration to Develop Antibody ...

The expansion demonstrates the success of their initial collaboration and AbCellera's capabilities in antibody discovery and development.

AbCellera and Lilly to Co-develop Antibody Therapies for the ...

AbCellera is a privately held company that engages in partnerships to discover and develop next-generation therapeutic antibodies. AbCellera's ...

abcl-20240630 - SEC.gov

... antibody discovery campaigns selected by our partners. ... While our partnership with Lilly has produced bamlanivimab and bebtelovimab, antibodies for which Lilly ...

AbCellera Announces Multi-Year Antibody Discovery Collaboration ...

AbCellera will use its world-leading antibody drug discovery platform in a multi-year collaboration to identify antibodies against up to nine targets.

Prelude Therapeutics and AbCellera Enter Partnership to Develop ...

... antibody discovery and development engine to generate novel precision antibody drug conjugates (ADCs). The first program, which benefits ...

AbCellera partners with American pharmaceutical company on multi ...

AbCellera partners with American pharmaceutical company on multi-year antibody discovery project ... Under the terms of the agreement with Lilly, ...

S-1 - SEC.gov

In March 2020, we entered into a discovery partnership agreement with Eli Lilly ... antibody discovery research for our partners. To a lesser extent, we ...

AbCellera Biologics, Inc. - Drug pipelines, Patents, Clinical trials

Abstract In this study, we describe the discovery of antibodies against a MAGE-A4 peptide-major histocompatibility complex (pMHC). These antibodies will form ...

AbCellera Biologics Inc. - cloudfront.net

... antibody discovery capabilities partner ... partnership with Lilly has produced bamlanivimab and bebtelovimab, antibodies for which Lilly ...

AbCellera in COVID-19 antibody discovery pact with Eli Lilly

The two companies will partner to work on the discovery of nine antibodies, with the initial target being COVID-19-related.